• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TRIGL; TRIGLYCERIDES GPO WITHOUT FREE GLYCEROL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TRIGL; TRIGLYCERIDES GPO WITHOUT FREE GLYCEROL Back to Search Results
Catalog Number 05171407190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/04/2022
Event Type  malfunction  
Manufacturer Narrative
Na.
 
Event Description
The initial reporter stated that 4 samples collected from the same patient and tested with trigl triglycerides on a cobas 8000 c (701) module.The specific date the event occurred was requested, but not provided.The customer stated that triglyceride measurements of the 4 samples yielded high results of > 1000 mg/dl.The measurements were not considered plausible by the customer as they did not agree with other diagnostic findings of the patient.The results from three of the four samples were reported outside of the laboratory with a comment stating the results were not plausible.The serial number of the c 701 analyzer is 17j2-08.
 
Manufacturer Narrative
A sample from the patient was provided for investigation.The sample was analyzed with the roche trigl triglycerides reagent (trigl) and with a special laboratory batch of the triglycerides reagent (trigla) which does not contain any lipoprotein lipase and thus only records the content of free glycerol in the sample.The difference between the two measurements, trigl = 28.0 mmol/l and trigla = 26.2 mmol/l, results in a difference of 1.8 mmol/l triglycerides.This corresponds to the true level of triacylglycerides in the sample.The measured value of free glycerol in the sample, 26.2 mmol/l, confirms the finding of pseudo hypertriglyceridemia due to the lack of glycerol kinase activity in the patient sample.The investigation concludes the patient suffers from pseudo hypertriglyceridemia due to a lack of glycerol kinase.There is no interference through drugs.The issue is sample-specific.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIGL
Type of Device
TRIGLYCERIDES GPO WITHOUT FREE GLYCEROL
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key13869625
MDR Text Key297804309
Report Number1823260-2022-00829
Device Sequence Number1
Product Code CDT
UDI-Device Identifier04015630925117
UDI-Public04015630925117
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K873049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05171407190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CYCLOPHOSPHAMID; MYCOPHENOLAT
-
-